Evaluation of the steroid ointment utility to prevent the injection site reactions and phlebitis caused by vinorelbine.
Not Applicable
- Conditions
- cancer
- Registration Number
- JPRN-UMIN000001065
- Lead Sponsor
- agasaki Thoracic Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
Hypersensivity to steroid ointment. Treating with steroid. Having no adequate vessel to observe phlebitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method